A researcher in a lab looking at a tablet.

ALK+ Blog/News

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Clinical Trial Spotlight: Tumor-Infiltrating Lymphocyte Therapy for ALK-Positive NSCLC at Moffitt Cancer Center

    For ALK-positive patients who have progressed after targeted therapy, a new clinical trial at Moffitt Cancer Center offers renewed hope. This Phase 1 study explores an enhanced form of Tumor-Infiltrating Lymphocyte (TIL) therapy—empowering a patient’s own immune cells with a genetic boost to better recognize and fight cancer. With its focus on ALK, EGFR, ROS1,…

    Read More

  • ,

    Patient Spotlight: Rick Meyer

    We interviewed long term survivor Rick Meyer on his experience with multiple ALK TKIs, his participation in the Nuvalent clinical trial for almost two years and counting, and his overall attitude to life as a thriving ALK patient.

    Read More

  • Stronger Every Day: How Movement and Community Keep Me Going

    When Michele walked into PVolve, she was looking for a way to reconnect with her body after a life-changing cancer diagnosis. What she found was so much more—a community that believed in her, showed up for her, and helped her raise nearly $5,000 for ALK-positive lung cancer research. This is her story of movement, resilience,…

    Read More

  • Trivia for a Cure: How Nikki Turned a Night of Fun into a Force for Research

    Nikki never imagined hosting a fundraiser in her name—let alone speaking publicly about her diagnosis. But when her community rallied around her, Trivia Night for a Cause became more than an event. It became a moment of courage, connection, and clarity. Learn how Nikki raised over $6,000 for ALK research and helped start an annual…

    Read More

  • $8 to the Greats: Because Great Things Start Small

    Suzanne believes in the power of small gifts and strong communities. That’s why she launched 8 to the Greats—a way for anyone to give $8 a month to fund lifesaving ALK research. Because we’re truly stronger together.

    Read More

  • A Journey of Purpose: How One Traveler Turned Airfare into Hope

    After two decades in the travel industry, Keng was diagnosed with ALK-positive lung cancer—and everything changed. Blending his professional expertise with a new sense of purpose, he created HealthcareFares.com, a platform that lets travelers save on flights and fund cancer research at no extra cost.

    Read More

  • photo of Celeste Olinger standing with others for lung cancer advocacy

    Patient Spotlight: Celeste Olinger Denver, Colorado, USA

    We interviewed long-term ALK survivor, Celeste Olinger, about her somewhat unusual cancer journey, her life, and her new normal since her diagnosis that still keeps her grounded and allows her to thrive.

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Clinical Trials for ALK-positive Cancers – Are They for Me?

    Should I enroll in a clinical trial for ALK-positive cancer? The decision to enroll in a clinical trial requires a real understanding of what is being studied and how you […]

    Read More

  • The United States Capitol exterior.

    Protect Funding for Lung Cancer and ALK-positive Cancer Research

    ATLANTA, February 20, 2025 – The ALK Positive organization stands with patients, families, healthcare providers, researchers, and the broader medical community in our mission to increase survival for those at risk, diagnosed, and living with ALK-positive cancer. We are deeply concerned with the devastating impact that severely and suddenly reducing the budget of the National…

    Read More

  • A grid of people participating in a video chat on a laptop screen.

    RAISE YOUR VOICE AS A CANCER PATIENT: Advocacy Letter Template

    Dear Senator (or Congress woman/man) XXXXX, As one of your constituents from XXXXXX, I wanted to let you know that I am deeply concerned about the current administration’s funding cuts to NIH. For the past XXX years I have been living with stage 4 lung cancer – ALK positive – a subtype that has FDA…

    Read More

  • ALK Positive Inc.'s Scientific Advisory Board.
    ,

    ALK Positive Announces Formation of Distinguished Scientific Advisory Board

    ALK Positive, in collaboration with 23andMe Holding Co., a leading genetic health and biopharmaceutical company, and 20 lung cancer advocacy organizations, today announces a new study to help advance research in lung cancer. The focus of the Lung Cancer Genetics Study is to better understand the genetics of people with lung cancer in order to…

    Read More

  • Dana Querido at the ocean.

    Dana Querido

    We interviewed patient and ALK Positive volunteer Dana Querido about her journey with ALK+ lung cancer and her active involvement with the ALKtALK Healing Arts, Death Cafe, and more.

    Read More